A closer look over Brexit’s impact on research and publishing

Although the impact of Brexit on research is still unknown, BMJ’s CEO Peter Ashman is confident medical publishing “will be OK”.

In this special podcast, Publishing Director of BMJ, Allison Lang, assures the American audience of JNIS that the turmoil in the UK over leaving the European Union should have no impact on the specialty journals of the BMJ Publishing Group.